Items where Author is "Farag, Mohamed"

Number of items: 26.
  • The junctional protein associated with coronary artery disease predicts adverse cardiovascular events in patients with acute coronary syndromes at high residual risk. (2025) Simon Kraler, Luca Liberale, Amedeo Tirandi, Margherita Moriero, Yifan Wang, Mohamed Farag, Federico Carbone, Maria B Bertolotto, Valentina Pusterla, Davide Ramoni, Stefano Ministrini, Yustina M Puspitasari, Francesco Bruno, Lorenz Räber, Davide Di Vece, Christian Templin, Olivier Muller, François Mach, Filippo Crea, Giovanni G Camici, Tetiana Lapikova-Bryhinska, Alexander Akhmedov, Arnold von Eckardstein, Diana A Gorog, Fabrizio Montecucco and Thomas F Lüscher picture_as_pdf
  • Safety of factor XI inhibitors compared to factor X inhibitors in atrial fibrillation: a systematic review and meta-analysis. (2025) Rafaella I. L. Markides, Sogol Koolaji, Joshua H. Leader, Mohamed Farag and Diana A. Gorog
  • Balloon Aortic Valvuloplasty Prior to Self‐Expanding TAVI: The BAVSE‐TAVI Registry. (2025) Abdalazeem Ibrahem, Ahmed Abdalwahab, Diana A. Gorog, Debbie Stewart, Rajiv Das, Richard Edwards, Mohaned Egred, Azfar Zaman, Mohammad Alkhalil and Mohamed Farag
  • Comparison of De-escalation of DAPT Intensity or Duration in East Asian and Western Patients with ACS Undergoing PCI: A Systematic Review and Meta-analysis. (2023) Diana Gorog, Visvesh Jeyalan, Rafaella I. L. Markides, Eliano P Navarese, Young-Hoon Jeong and Mohamed Farag
  • Reduction or de-escalation of dual antiplatelet therapy intensity or duration in patients with acute coronary syndromes undergoing percutaneous coronary intervention: A mini-review. (2022) Mohamed Farag, Visvesh Jeyalan, Jose Luis Ferreiro, Young-Hoon Jeong, Tobias Geisler and Diana A. Gorog
  • Spontaneous reperfusion in patients with transient ST-elevation myocardial infarction - prevalence, importance and approaches to management. (2021) Mohamed Farag, Marta Peverelli, Nikolaos Spinthakis, Ying X. Gue, Mohaned Egred and Diana Gorog
  • Non-Vitamin K Antagonist Oral Anticoagulants versus Warfarin for Patients with Left Ventricular Thrombus: A Systematic Review and Meta-analysis. (2021) Ying X. Gue, Nikolaos Spinthakis, Mohaned Egred, Diana Gorog and Mohamed Farag
  • Precision treatment in ACS – role of assessing fibrinolysis. (2021) Ying X. Gue, Young-Hoon Jeong, Mohamed Farag, Nikolaos Spinthakis and Diana Gorog
  • Effect of remote ischaemic conditioning on platelet reactivity and endogenous fibrinolysis in ST-elevation myocardial infarction- a substudy of the CONDI-2/ERIC4 PPCI randomised controlled trial. (2020) Diana Gorog, Mohamed Farag, Nikolaos Spinthakis, Derek M. Yellon, Hans E Bøtker†, Rajesh Kharbanda and Derek Hausenloy
  • Impact of Preadmission Morphine on Reinfarction in Patients With ST-Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention : A Meta-Analysis. (2020) Ying Gue, Nikolaos Spinthakis, Mohamed Farag, Jacek Kubica, Jolanta M Siller-Matula, Manivannan Srinivasan and Diana Gorog
  • Relationship of platelet reactivity and inflammatory markers to recurrent adverse events in patients with ST-elevation myocardial infarction. (2019) Krishma Adatia, Mohamed Farag, Ying X. Gue, Manivannan Srinivasan and Diana Gorog
  • Apixaban Enhances Endogenous Fibrinolysis in Patients with Atrial Fibrillation. (2019) Nikolaos Spinthakis, Ying X. Gue, Mohamed Farag, Manivannan Srinivasan, David Wellsted, Gregory Y H Lip, Deepa RJ Arachchillage and Diana Gorog
  • Impaired endogenous fibrinolysis at high shear using a point-of-care test in STEMI is associated with alterations in clot architecture. (2019) Nikolaos Spinthakis, Ying Gue, Mohamed Farag, Guogang Ren, Manivannan Srinivasan, Anwar Baydoun and Diana A Gorog
  • Impaired endogenous fibrinolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events : the RISK PPCI study. (2019) Mohamed Farag, Nikolaos Spinthakis, Ying X. Gue, Manivannan Srinivasan, Keith Sullivan, David Wellsted and Diana A. Gorog picture_as_pdf
  • Morphine Analgesia Pre-PPCI Is Associated with Prothrombotic State, Reduced Spontaneous Reperfusion and Greater Infarct Size. (2018) Mohamed Farag, Nikolaos Spinthakis, Manivannan Srinivasan, Keith Sullivan, David Wellsted and Diana A Gorog
  • More, More, More: Reducing Thrombosis in Acute Coronary Syndromes Beyond Dual Antiplatelet Therapy-Current Data and Future Directions. (2018) Nikolaos Spinthakis, Mohamed Farag, Bianca Rocca and Diana Gorog
  • Is there a role for oral triple therapy in patients with acute coronary syndromes without atrial fibrillation? (2018) Nikolaos Spinthakis, Mohamed Farag, Zaki Akhtar and Diana Adrienne Gorog
  • Percutaneous coronary intervention with drug-eluting stent versus coronary artery bypass grafting : A meta-analysis of patients with left main coronary artery disease. (2017) Nikolaos Spinthakis, Mohamed Farag, Diana A Gorog, Abhiram Prasad, Hamid Mahmood, Ying Gue, David Wellsted, Ashraf Nabhan and Manivannan Srinivasan
  • Catheter ablation for AF improves global thrombotic profile and enhances fibrinolysis. (2017) Maria Niespialowska-Steuden, Vias Markides, Mohamed Farag, David Jones, Wajid Hussain, Tom Wong and Diana A Gorog
  • Impaired thrombolytic status predicts adverse cardiac events in patients undergoing primary percutaneous coronary intervention. (2017) Christos Christopoulos, Mohamed Farag, Keith Sullivan, David Wellsted and Diana A Gorog picture_as_pdf
  • Nitrates for the Management of Acute Heart Failure Syndromes, A Systematic Review. (2017) Mohamed Farag, Ahmad Shoaib and Diana A Gorog picture_as_pdf
  • Spontaneous Coronary Artery Dissection : The Phantom Menace. (2016) Nikolaos Spinthakis, Nada Abdulkareem, Mohamed Farag and Diana A Gorog
  • Relative effects of different non-vitamin K antagonist oral anticoagulants on global thrombotic status in atrial fibrillation. (2016) Mohamed Farag, Maria Niespialowska-Steuden, Osita Okafor, Benjamin Artman, Manivannan Srinivasan, Arif Khan, Keith Sullivan, David Wellsted and Diana A Gorog picture_as_pdf
  • Use of bioresorbable vascular scaffold : a meta-analysis of patients with coronary artery disease. (2016) Mohamed Farag, Nikolaos Spinthakis, Diana A Gorog, Abhiram Prasad, Keith Sullivan, Zaki Akhtar, Neville Kukreja and Manivannan Srinivasan
  • Bivalirudin versus unfractionated heparin : a meta-analysis of patients receiving percutaneous coronary intervention for acute coronary syndromes. (2015) Mohamed Farag, Diana A Gorog, Abhiram Prasad and Manivannan Srinivasan
  • Adjunctive therapies to reduce thrombotic events in patients with a history of myocardial infarction : role of vorapaxar. (2015) Mohamed Farag, Hiten Patel and Diana A Gorog